Skip to main content

Table 2 Reduction of migraine days

From: Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial

Days with migraine (SD) Verum Placebo P value
  N = 55 N = 57  
Baseline 6.2 (1.95) 6.5 (1.78) -
Treatment 1st month 5.0 (3.39) 5.7 (3.03) 0.37
Treatment 2nd month 4.8 (3.29) 5.5 (3.01) 0.39
Treatment 3rd month 4.4 (2.99) 5.2 (3.22) 0.23